Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H.
Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
WIEN KLIN WOCHENSCHR. 2019; 131(1-2): 47-47.
Doi: 10.1007/s00508-018-1428-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Autor*innen der Med Uni Graz:
-
Wölfler Albert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Correction to:Wien Klin Wochenschr 2018 https://doi.org/10.1007/s00508-018-1365-5 The original version of this article unfortunately contained a mistake. Table Nr. 1 was inconsistent. The corrected version of Table 1 is given below. We apologize for any inconveniences this may have ….